Showing results (111-120 of 374) with videos related to

Sort By:
Pageof 38
Cureus|October 18, 2021
Regenerative Injection Treatments Utilizing Platelet Products and Prolotherapy for Cervical Spine Pain: A Functional Spinal Unit ApproachChristopher Williams, Mairin Jerome, Chaz Fausel, et al.
ACS Medicinal Chemistry Letters|April 17, 2015
Lead optimization of spiropyrazolopyridones: a new and potent class of dengue virus inhibitorsBin Zou, Wai Ling Chan, Mei Ding, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|October 26, 2010
Preliminary evaluation of a new technique of minimally invasive surfactant therapyPeter A Dargaville, Ajit Aiyappan, Anita Cornelius, et al.
Frontiers in Digital Health|August 22, 2022
Effectiveness of a hybrid digital substance abuse prevention approach combining e-Learning and in-person class sessionsKenneth W Griffin, Christopher Williams, Caroline M Botvin, et al.
Substance Use & Misuse|June 25, 2005
Efficacy of a drug prevention CD-ROM intervention for adolescentsChristopher Williams, Kenneth W Griffin, Araxi P Macaulay, et al.
Biomedicines|October 29, 2025
Long-Term Effectiveness of Intradiscal Culture-Expanded Mesenchymal Stem Cells (MSCs) with Platelet Products for Discogenic Low Back PainNicholas Hooper, Joseph Ierulli, Chase Demarest, et al.
Medrxiv : the Preprint Server for Health Sciences|January 30, 2023
Application of Elastic Net Regression for Modeling COVID-19 Sociodemographic Risk FactorsTristan A Moxley, Jennifer Johnson-Leung, Erich Seamon, et al.
Plos One|January 26, 2024
Application of elastic net regression for modeling COVID-19 sociodemographic risk factorsTristan A Moxley, Jennifer Johnson-Leung, Erich Seamon, et al.
Pilot and Feasibility Studies|December 15, 2016
Evaluating an online support package delivered within a disability unemployment service: study protocol for a randomised controlled feasibility studyCarrie-Anne McClay, Stuart Rae, Jill Morrison, et al.
Investigational New Drugs|July 11, 2020
Subcellular distribution and mechanism of action of AL906, a novel and potent EGFR inhibitor rationally designed to be green fluorescentNahid Golabi, Anne-Laure Larroque, Lisa Peyrard, et al.
Pageof 38